Cargando…

Lichenoid drug eruption due to imatinib mesylate

Imatinib mesylate is a selective tyrosinase kinase inhibitor which has revolutionized the treatment of chronic myeloid leukemia. It is also used in gastrointestinal stromal tumors and dermatofibrosarcoma protruberans. Cutaneous adverse reactions are the most common nonhematological side effects seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatia, Anuradha, Kanish, Bimal, Chaudhary, Paulina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318107/
https://www.ncbi.nlm.nih.gov/pubmed/25664274
http://dx.doi.org/10.4103/2229-516X.149253

Ejemplares similares